Advanced Medical Solutions Group plc (LON:AMS) Increases Dividend to GBX 1.83 Per Share

Advanced Medical Solutions Group plc (LON:AMS - Get Free Report) declared a dividend on Wednesday, March 19th, DividendData.Co.Uk reports. Investors of record on Thursday, May 29th will be given a dividend of GBX 1.83 ($0.02) per share on Friday, June 20th. This represents a yield of 0.89%. The ex-dividend date of this dividend is Thursday, May 29th. This is a 137.7% increase from Advanced Medical Solutions Group's previous dividend of $0.77. The official announcement can be accessed at this link.

Advanced Medical Solutions Group Price Performance

Shares of Advanced Medical Solutions Group stock traded down GBX 7.70 ($0.10) on Friday, reaching GBX 196.80 ($2.54). 2,104,277 shares of the stock were exchanged, compared to its average volume of 869,162. The company has a debt-to-equity ratio of 37.01, a quick ratio of 4.58 and a current ratio of 8.39. The firm has a market cap of £424.94 million, a PE ratio of 38.14, a P/E/G ratio of 5.00 and a beta of 0.74. The firm's 50 day moving average is GBX 211.70 and its 200-day moving average is GBX 212.12. Advanced Medical Solutions Group has a one year low of GBX 176.60 ($2.28) and a one year high of GBX 275.83 ($3.56).

Advanced Medical Solutions Group (LON:AMS - Get Free Report) last issued its quarterly earnings results on Thursday, March 20th. The company reported GBX 10.65 ($0.14) earnings per share (EPS) for the quarter. Advanced Medical Solutions Group had a return on equity of 4.57% and a net margin of 8.49%. As a group, analysts anticipate that Advanced Medical Solutions Group will post 9.8159509 EPS for the current fiscal year.

Remove Ads

Wall Street Analyst Weigh In

Separately, Berenberg Bank restated a "buy" rating and set a GBX 300 ($3.87) price objective on shares of Advanced Medical Solutions Group in a research report on Wednesday.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.